Design of potent, non-toxic anticancer peptides based on the structure of the antimicrobial peptide, temporin-1CEa

[1]  D. Phoenix,et al.  Cationic Antimicrobial Peptides , 2013 .

[2]  D. Ausbacher,et al.  Anticancer mechanisms of action of two small amphipathic β(2,2)-amino acid derivatives derived from antimicrobial peptides. , 2012, Biochimica et biophysica acta.

[3]  E. Paredes-Gamero,et al.  Characterization of dual effects induced by antimicrobial peptides: regulated cell death or membrane disruption. , 2012, Biochimica et biophysica acta.

[4]  D. Shang,et al.  Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis). , 2012, Biochimie.

[5]  Justin Dassie.  Selective targeting of cancer cells with RNA aptamers , 2012 .

[6]  R. Hodges,et al.  Rational Design of α‐Helical Antimicrobial Peptides to Target Gram‐negative Pathogens, Acinetobacter baumannii and Pseudomonas aeruginosa: Utilization of Charge, ‘Specificity Determinants,’ Total Hydrophobicity, Hydrophobe Type and Location as Design Parameters to Improve the Therapeutic Ratio , 2011, Chemical biology & drug design.

[7]  Yibing Huang,et al.  Studies on Mechanism of Action of Anticancer Peptides by Modulation of Hydrophobicity Within a Defined Structural Framework , 2011, Molecular Cancer Therapeutics.

[8]  Y. Li,et al.  Molecular Cloning of cDNAs Encoding Antimicrobial Peptide Precursors from the Skin of the Chinese Brown Frog, Rana chensinensis , 2009, Zoological science.

[9]  C. Mant,et al.  Intrinsic amino acid side‐chain hydrophilicity/hydrophobicity coefficients determined by reversed‐phase high‐performance liquid chromatography of model peptides: Comparison with other hydrophilicity/hydrophobicity scales , 2009, Biopolymers.

[10]  D. Hoskin,et al.  Studies on anticancer activities of antimicrobial peptides. , 2008, Biochimica et biophysica acta.

[11]  C. Mant,et al.  Role of Peptide Hydrophobicity in the Mechanism of Action of α-Helical Antimicrobial Peptides , 2006, Antimicrobial Agents and Chemotherapy.

[12]  R. Hancock,et al.  Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies , 2006, Nature Biotechnology.

[13]  D. Hoskin,et al.  Cationic antimicrobial peptides as novel cytotoxic agents for cancer treatment , 2006, Expert opinion on investigational drugs.

[14]  R. Hancock,et al.  Peptide Antimicrobial Agents , 2006, Clinical Microbiology Reviews.

[15]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[16]  M. Gottesman,et al.  Targeting multidrug resistance in cancer , 2006, Nature Reviews Drug Discovery.

[17]  Robert E W Hancock,et al.  Comparison of Biophysical and Biologic Properties of α‐Helical Enantiomeric Antimicrobial Peptides , 2006, Chemical biology & drug design.

[18]  C. Mant,et al.  Determination of intrinsic hydrophilicity/hydrophobicity of amino acid side chains in peptides in the absence of nearest-neighbor or conformational effects. , 2006, Biopolymers.

[19]  C. Leuschner,et al.  Membrane disrupting lytic peptides for cancer treatments. , 2004, Current pharmaceutical design.

[20]  Mouldy Sioud,et al.  Selective targeting of cancer cells using synthetic peptides. , 2003, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[21]  Tim J. Carver,et al.  The design of Jemboss: a graphical user interface to EMBOSS , 2003, Bioinform..

[22]  Niv Papo,et al.  A Novel Lytic Peptide Composed of dl-Amino Acids Selectively Kills Cancer Cells in Culture and in Mice* , 2003, Journal of Biological Chemistry.

[23]  Michael R. Yeaman,et al.  Mechanisms of Antimicrobial Peptide Action and Resistance , 2003, Pharmacological Reviews.

[24]  C. Deber,et al.  Cationic Hydrophobic Peptides with Antimicrobial Activity , 2002, Antimicrobial Agents and Chemotherapy.

[25]  Y. Shai,et al.  The Consequence of Sequence Alteration of an Amphipathic α-Helical Antimicrobial Peptide and Its Diastereomers* , 2002, The Journal of Biological Chemistry.

[26]  C. Mant,et al.  Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix. , 2002, The journal of peptide research : official journal of the American Peptide Society.

[27]  Y. Shai,et al.  Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. , 1999, Biochimica et biophysica acta.

[28]  J. Cuzick.  Chemoprevention of breast cancer — An update , 1998 .

[29]  E. Krause,et al.  Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. , 1997, Biochemistry.

[30]  M. Dathe,et al.  Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides , 1997, FEBS letters.

[31]  J. Styles,et al.  Chemoprevention of Breast Cancer by Tamoxifen: Risks and Opportunities , 2000, Toxicology letters.

[32]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[33]  David Eisenberg,et al.  The helical hydrophobic moment: a measure of the amphiphilicity of a helix , 1982, Nature.